Get started
Author

Leyi Yao

Broad Spectrum Deubiquitinase Inhibition Induces Both Apoptosis and Ferroptosis in Cancer Cells
2020 · Li Yang, Xin Chen, et al. · Frontiers in Oncology · 102
PDF
Bilirubin ameliorates murine atherosclerosis through inhibiting cholesterol synthesis and reshaping the immune system
2022 · Guanmei Wen, Leyi Yao, et al. · Journal of Translational Medicine · 80
PDF
Plumbagin is a novel GPX4 protein degrader that induces apoptosis in hepatocellular carcinoma cells
2023 · Leyi Yao, Ding Yan, et al. · Free Radical Biology and Medicine · 66
A new role of GRP75-USP1-SIX1 protein complex in driving prostate cancer progression and castration resistance
2021 · Yuning Liao, Yuan Liu, et al. · Oncogene · 43
Regulation of Bax-dependent apoptosis by mitochondrial deubiquitinase USP30
2021 · Ding Yan, Xiaofen Li, et al. · Cell Death Discovery · 22
PDF
Eupalinolide B suppresses pancreatic cancer by ROS generation and potential cuproptosis
2024 · Qingtian Huang, Jie Yang, et al. · iScience · 19
Research Progress on the Role and Mechanism of IL-37 in Liver Diseases
2023 · Baoyi Jiang, Yulin Zhou, et al. · Seminars in Liver Disease · 18
PDF
Short Term Exposure to Bilirubin Induces Encephalopathy Similar to Alzheimer’s Disease in Late Life
2019 · Haoyu Chen, Lu Liang, et al. · Journal of Alzheimer s Disease · 18
Pathological Significance and Prognostic Roles of Indirect Bilirubin/Albumin Ratio in Hepatic Encephalopathy
2021 · Yanling Li, Huiyuan Liu, et al. · Frontiers in Medicine · 17
PDF
UCHL3 augments cuproptosis via PKM2 deubiquitination in hepatocellular carcinoma
2025 · Leyi Yao, Shuhui Ye, et al. · Free Radical Biology and Medicine · 9
Strategies to combat cancer drug resistance: focus on copper metabolism and cuproptosis
2025 · Leyi Yao, Baoyi Jiang, et al. · Cancer Drug Resistance · 8
Bilirubin inhibits the anticancer activity of sorafenib by blocking MCL-1 degradation in hepatocellular carcinoma cells
2022 · Leyi Yao, Qian Zhao, et al. · Cancer Biology and Medicine · 7
PDF
Cullin 2‐RBX1 E3 ligase and USP2 regulate antithrombin ubiquitination and stability
2021 · Dacai Xu, Jiawen Wu, et al. · The FASEB Journal · 7
PDF
WBP11 inhibits UFL1-mediated UFMylation of NONO to drive hepatocellular carcinoma progression
2025 · Hongbiao Huang, Yujie Xiang, et al. · Oncogene · 5
Induction of Heme Oxygenase-1 Modifies the Systemic Immunity and Reduces Atherosclerotic Lesion Development in ApoE Deficient Mice
2022 · Leyi Yao, Yali Hao, et al. · Frontiers in Pharmacology · 5
PDF
Bilirubin inhibits lung carcinogenesis by up-regulating cystatin A expression in tumor-infiltrating macrophages
2023 · Qingtian Huang, Na Zhang, et al. · Genes & Diseases · 3
Bilirubin Restrains the Anticancer Effect of Vemurafenib on BRAF-Mutant Melanoma Cells Through ERK-MNK1 Signaling
2021 · Yufan Tan, Xiaoyu Zhong, et al. · Frontiers in Oncology · 3
PDF
The GCN5L2-SIX1 complex drives glycolysis to promote progression of triple-negative breast cancer
2026 · Yuning Liao, Shusha Yin, et al. · Cancer Letters · 2
Schisandrin B downregulates exosomal fibronectin 1 expression to inhibit hepatocellular carcinoma growth
2025 · Baoyi Jiang, Jie Yang, et al. · Frontiers in Pharmacology · 1
Bilirubin Restrains the Anticancer Effects of Vemurafenib on BRAF-Mutant Melanoma Cells via ERK-MNK1 Signaling
2021 · Xiaoyu Zhong, Yufan Tan, et al. · SSRN Electronic Journal
Works count: 20
Citation count: 435
H-index: 9
I10-index: 9
Year
Topic
Type